HU0203885A3 - Novel tiotropium-containing inhalation powder, process for its preperation and its use - Google Patents

Novel tiotropium-containing inhalation powder, process for its preperation and its use

Info

Publication number
HU0203885A3
HU0203885A3 HU0203885A HU0203885A HU0203885A3 HU 0203885 A3 HU0203885 A3 HU 0203885A3 HU 0203885 A HU0203885 A HU 0203885A HU 0203885 A HU0203885 A HU 0203885A HU 0203885 A3 HU0203885 A3 HU 0203885A3
Authority
HU
Hungary
Prior art keywords
preperation
process
use
inhalation powder
containing inhalation
Prior art date
Application number
HU0203885A
Other versions
HU226982B1 (en
HU0203885A2 (en
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to DE10050635 priority Critical
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Priority to PCT/EP2001/011227 priority patent/WO2002030389A1/en
Publication of HU0203885A2 publication Critical patent/HU0203885A2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU0203885(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of HU0203885A3 publication Critical patent/HU0203885A3/en
Publication of HU226982B1 publication Critical patent/HU226982B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
HU0203885A 2000-10-12 2001-09-28 Novel tiotropium-containing inhalation powder, process for its preperation and its use HU226982B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
PCT/EP2001/011227 WO2002030389A1 (en) 2000-10-12 2001-09-28 Novel tiotropium-containing inhalation powder

Publications (3)

Publication Number Publication Date
HU0203885A2 HU0203885A2 (en) 2003-03-28
HU0203885A3 true HU0203885A3 (en) 2005-01-28
HU226982B1 HU226982B1 (en) 2010-04-28

Family

ID=7659578

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203885A HU226982B1 (en) 2000-10-12 2001-09-28 Novel tiotropium-containing inhalation powder, process for its preperation and its use

Country Status (47)

Country Link
US (4) US7070800B2 (en)
EP (2) EP1430887A1 (en)
JP (1) JP3870159B2 (en)
CN (1) CN1210017C (en)
AP (1) AP1712A (en)
AR (1) AR031819A1 (en)
AT (1) AT275391T (en)
AU (1) AU757008B2 (en)
BG (1) BG65753B1 (en)
BR (1) BR0107304A (en)
CA (1) CA2395653C (en)
CR (1) CR6937A (en)
CU (1) CU23284B7 (en)
CZ (1) CZ301465B6 (en)
DE (1) DE50103551C5 (en)
DK (1) DK1292281T3 (en)
DZ (1) DZ3477A1 (en)
EA (1) EA004034B1 (en)
EC (2) ECSP024268A (en)
EE (1) EE04414B1 (en)
EG (1) EG24139A (en)
ES (1) ES2227268T3 (en)
GE (1) GEP20063865B (en)
HK (1) HK1051812A1 (en)
HR (1) HRP20020437B1 (en)
HU (1) HU226982B1 (en)
IL (2) IL149984D0 (en)
IS (1) IS2360B (en)
MA (1) MA25843A1 (en)
ME (2) ME00245B (en)
MX (1) MXPA02005666A (en)
NO (1) NO331956B1 (en)
NZ (1) NZ519406A (en)
OA (1) OA12522A (en)
PE (1) PE05772002A1 (en)
PL (1) PL200063B1 (en)
PT (1) PT1292281E (en)
RS (1) RS50197B (en)
SA (1) SA1493B1 (en)
SI (1) SI1292281T1 (en)
SK (1) SK285389B6 (en)
TR (1) TR200402367T4 (en)
TW (1) TWI285553B (en)
UA (1) UA72014C2 (en)
UY (1) UY26959A1 (en)
WO (1) WO2002030389A1 (en)
ZA (2) ZA200204378B (en)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2474199T3 (en) 2000-11-30 2014-07-08 Vectura Limited Pharmaceutical compositions for inhalation
RS50197B (en) 2000-10-12 2009-05-06 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Novel tiotropium-containing inhalation powder
ES2689704T3 (en) 2000-11-30 2018-11-15 Vectura Limited Particles for use in a pharmaceutical composition
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
DE10128779A1 (en) * 2001-06-13 2003-01-02 Boehringer Ingelheim Pharma A process for the cleaning of hard gelatin capsules
DE10141377A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Sprinkling method for preparation of powder formulations
DE10141376A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Process for preparing inhalable powders
DE10212264A1 (en) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
JP2005526103A (en) * 2002-04-04 2005-09-02 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Powder formulation suitable for inhalation
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
BR0311747A (en) * 2002-06-12 2005-06-07 Epigenesis Pharmaceuticals Inc Pharmaceutical composition as single dose or multiple dose of the composition, kit and method for treating disease
JP2006516531A (en) * 2002-08-21 2006-07-06 ノートン ヘルスケアー リミテッドNorton Healthcare Ltd. Inhalation composition
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
EA007377B1 (en) * 2002-08-21 2006-10-27 Нортон Хелткэа Лтд. Compositions for inhalation
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
DE10255387A1 (en) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg New tiotropium containing powder formulation for inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20050058606A1 (en) * 2002-12-16 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing HFC solution formulations
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
CN100515392C (en) 2003-03-07 2009-07-22 南昌弘益科技有限公司 Dry powder composition for improvement of effective position medical deposit
DE10317461A1 (en) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US7954491B2 (en) * 2003-06-13 2011-06-07 Civitas Therapeutics, Inc. Low dose pharmaceutical powders for inhalations
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
PT1682541E (en) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Method for producing tiotropium salts
RS20060293A (en) * 2003-11-03 2008-08-07 Boehringer Ingelheim International Gmbh., Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
SE0303570A (en) * 2003-12-03 2005-06-04 Microdrug Ag Moisture-sensitive medical product
PL1691783T3 (en) * 2003-12-03 2010-05-31 Boehringer Ingelheim International Gmbh Pre-metered dry powder inhaler for moisture-sensitive medicaments
SE0303270A (en) * 2003-12-03 2005-06-04 Microdrug Ag Method for administration of tiotropium
CA2547782A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303269A (en) * 2003-12-03 2005-06-04 Microdrug Ag medical product
DE102004048389A1 (en) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifying surfaces of lactose as an excipient for use in powdered inhalants
EP3199164A1 (en) 2005-02-10 2017-08-02 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
PT1881980E (en) 2005-05-02 2012-12-06 Boehringer Ingelheim Int Novel crystalline forms of tiotropium bromide
RU2418796C2 (en) * 2005-06-15 2011-05-20 Берингер Ингельхайм Интернациональ Гмбх Method of producing novel tiotropium salts
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
RU2453547C2 (en) * 2005-12-19 2012-06-20 Сикор Инк. Novel forms of tiotropium bromide and synthesis methods thereof
EP1966196A2 (en) * 2005-12-19 2008-09-10 Sicor, Inc. Pure and stable tiotropium bromide
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
WO2007075858A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Novel forms of tiotropium bromide and processes for preparation thereof
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
US20100255307A1 (en) * 2007-07-27 2010-10-07 Cargill Inc. Micronization of polyols
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
EP2320821B1 (en) 2008-05-09 2012-10-24 Innovative Pulmonary Solutions, Inc. Systems for treating a bronchial tree
EP2172190A1 (en) 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
WO2010106988A1 (en) 2009-03-17 2010-09-23 第一三共株式会社 Amide derivative
EP2493408B1 (en) 2009-10-27 2015-06-24 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
CN102711645B (en) 2009-11-11 2016-12-28 赫莱拉公司 For processing tissue and narrow control systems and devices
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
US9259376B2 (en) 2010-06-03 2016-02-16 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Process for dry powder formulations
TR201007251A2 (en) * 2010-09-01 2012-03-21 Bilgiç Mahmut Calcium channel blocker formulation.
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
WO2013127738A1 (en) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Novel propellant-gas-containing tiotropium formulation
RU2522213C2 (en) * 2012-06-07 2014-07-10 Шолекс Девелопмент Гмбх, Pharmaceutical inhaled medication for treatment of bronchial asthma and chronic obstructive lung disease, containing micronised tiotropium bromide as active substance and method of its production
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
US20150224197A1 (en) * 2012-07-05 2015-08-13 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation compositions
WO2014007770A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising corticosteroid and sorbitol
WO2014007772A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007773A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and sorbitol
WO2014007769A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and glucose anhydrous
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
WO2015065222A1 (en) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Pharmaceutical inhaled drug with micronized tiotropium bromide as active ingredient for the treatment of bronchial asthma and chronic obstructive pulmonary disease and method for producing same
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US20180236188A1 (en) 2015-10-23 2018-08-23 Arven Ilac Sanayi Ve Ticaret A.S. Blister for inhalable formulation of tiotropium bromide

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
DE2540633C2 (en) 1975-09-12 1989-01-19 C.H. Boehringer Sohn, 6507 Ingelheim, De
DE3211185A1 (en) 1982-03-26 1983-09-29 Boehringer Ingelheim Kg New Quaternary 6,11-dihydro-dibenzo (b, e) thiepin-11-n-alkyl norscopinether and processes for their preparation
DE3215493A1 (en) 1982-04-26 1983-11-03 Boehringer Ingelheim Kg New intermediates, methods for their manufacture and their use
JPH0360620B2 (en) 1984-02-20 1991-09-17 Fanuc Ltd
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (en) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of Thienylcarbonsäuren with aminoalcohols, their quaternization products, processes for their preparation and pharmaceutical compositions containing them
DE4108393A1 (en) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg New esters bi-and tricyclic amino alcohols, their preparation and their use in medicinal products
US5770738A (en) 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
EP0580861B1 (en) 1991-04-08 1998-09-09 Nippon Shinyaku Company, Limited Sustained release capsule for adhesion in the gastrointestinal tract
DE4140689B4 (en) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
DE4318455A1 (en) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg capsule holder
GB9311892D0 (en) 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
EP1029538A3 (en) 1993-09-28 2003-10-15 Novartis AG Soft gelatin capsule manufacture
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (en) 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation
DE19515625C2 (en) 1995-04-28 1998-02-19 Boehringer Ingelheim Kg A process for preparing enantiomerically pure Tropasäureestern
FR2757173A1 (en) 1996-12-17 1998-06-19 Warner Lambert Co Polymeric compositions of non-animal origin for film formation
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
US6235725B1 (en) * 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
CN1150895C (en) 1998-11-13 2004-05-26 杰格研究股份公司 Dry Powder for inhalation
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
US20040002548A1 (en) 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
JP3931486B2 (en) 1999-06-24 2007-06-13 住友化学株式会社 The positive resist composition
RS50197B (en) * 2000-10-12 2009-05-06 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Novel tiotropium-containing inhalation powder
EP1326585B2 (en) * 2000-10-12 2010-09-29 Boehringer Ingelheim Pharma GmbH & Co. KG Method for producing powdery formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
DE10064816A1 (en) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Production of tiotropium bromide useful as an anticholinergic comprises oxidation of di-(2-thienyl)-glycolic acid tropenol ester and subsequent quaternisation
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
DE10126924A1 (en) 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
US6482429B1 (en) 2001-06-20 2002-11-19 Boehringer Ingelheim Pharmaceuticals, Inc. Stable powder inhalation dosage formulation
DE10141377A1 (en) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Sprinkling method for preparation of powder formulations
DE10141376A1 (en) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Process for preparing inhalable powders
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
JP2005526103A (en) 2002-04-04 2005-09-02 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト Powder formulation suitable for inhalation
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
CN100522135C (en) 2002-04-09 2009-08-05 贝林格尔英格海姆法玛两合公司 Inhalation kit comprisung inhalable powder of tiotropium
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation

Also Published As

Publication number Publication date
CN1210017C (en) 2005-07-13
EP1292281B1 (en) 2004-09-08
PL356840A1 (en) 2004-07-12
US20040228806A1 (en) 2004-11-18
IL149984A (en) 2007-06-03
NO331956B1 (en) 2012-05-14
HK1051812A1 (en) 2005-09-30
PT1292281E (en) 2004-11-30
MXPA02005666A (en) 2002-11-29
AP1712A (en) 2007-01-24
BG106730A (en) 2003-03-31
WO2002030389A1 (en) 2002-04-18
DE50103551D1 (en) 2004-10-14
UA72014C2 (en) 2002-10-15
DZ3477A1 (en) 2002-04-18
EE200200428A (en) 2003-02-17
CN1392795A (en) 2003-01-22
GEP20063865B (en) 2006-07-10
CR6937A (en) 2003-11-28
JP3870159B2 (en) 2007-01-17
CU23284B7 (en) 2008-06-30
ZA200303149B (en) 2004-05-07
AT275391T (en) 2004-09-15
US7070800B2 (en) 2006-07-04
NZ519406A (en) 2003-07-25
SI1292281T1 (en) 2004-12-31
IL149984D0 (en) 2002-12-01
EG24139A (en) 2008-08-06
BG65753B1 (en) 2009-10-30
ECSP024268A (en) 2002-08-01
PL200063B1 (en) 2008-12-31
SK285389B6 (en) 2006-12-07
UY26959A1 (en) 2002-06-20
AU757008B2 (en) 2003-01-30
HU0203885A2 (en) 2003-03-28
AR031819A1 (en) 2003-10-08
HRP20020437B1 (en) 2005-10-31
US20080292563A1 (en) 2008-11-27
YU36302A (en) 2002-09-19
EA004034B1 (en) 2003-12-25
ECSP034546A (en) 2003-06-25
MA25843A1 (en) 2003-07-01
JP2004510805A (en) 2004-04-08
CZ20021785A3 (en) 2002-09-11
ME00245B (en) 2011-02-10
AP200302774A0 (en) 2003-03-31
US20060039868A1 (en) 2006-02-23
SA1493B1 (en) 2006-10-31
TWI285553B (en) 2007-08-21
RS50197B (en) 2009-05-06
ZA200204378B (en) 2003-05-19
CZ301465B6 (en) 2010-03-10
ES2227268T3 (en) 2005-04-01
US20020110529A1 (en) 2002-08-15
EA200200551A1 (en) 2002-12-26
AU8993501A (en) 2002-04-22
MEP40108A (en) 2011-02-10
IS6771A (en) 2003-04-08
EE04414B1 (en) 2005-02-15
DK1292281T3 (en) 2004-10-11
HRP20020437A2 (en) 2004-08-31
IS2360B (en) 2008-05-15
OA12522A (en) 2006-05-30
PE05772002A1 (en) 2002-08-08
CA2395653A1 (en) 2002-04-18
TR200402367T4 (en) 2004-12-21
HU226982B1 (en) 2010-04-28
EP1292281A1 (en) 2003-03-19
NO20022414D0 (en) 2002-05-22
NO20022414L (en) 2002-05-30
SK7062002A3 (en) 2002-10-08
CA2395653C (en) 2006-05-09
EP1430887A1 (en) 2004-06-23
DE50103551C5 (en) 2014-08-21
BR0107304A (en) 2002-08-13

Similar Documents

Publication Publication Date Title
EG22308A (en) Tobacco treatment
GB2353222B (en) Inhalers
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
HU0302578A3 (en) Isoindole-imide compounds, compositions containing them, and use thereof
PT1308439E (en) Proline derivatives and use thereof as drugs
HU0301146A3 (en) 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use
HK1051676A1 (en) Magnesium-ammonium-phosphate cemente preparation, the production of the same and the use thereof, and the production on the cement
HU0302943A3 (en) New heterocyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
HU0400467A3 (en) 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
IL150594D0 (en) Purine derivatives, process for their preparation and use
AU2001284643A1 (en) De-agglomerator for breath-actuated dry powder inhaler
AU1397702A (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
PL375025A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
GB0031088D0 (en) Medicaments
IL191790A (en) Xanthine derivatives, their production and use thereof as medicaments
SG101535A1 (en) Aqueous dispersion, a process for the preparation and the use thereof
PL203124B1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
HU0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
HK1044338A1 (en) 5-Pyridyl-1, 3-azole compounds, process for producing the same and use thereof
AU4867301A (en) Nasal inhaler
IL159015D0 (en) Polypeptides, their preparation and use
ZA200107983B (en) New compounds, their preparation and use.
IL152461D0 (en) Directly compressed solid dosage articles
IL137979D0 (en) Production, release preparation for aii antagonist-sustained and use thereof